Keyphrases
30-day Mortality
33%
Adjusted Analysis
33%
Adjusted Odds Ratio
16%
Aminoglycosides
16%
Appropriate Empirical Antibiotic
100%
Appropriate Empirical Treatment
16%
Bacteremia
16%
Blood Culture
16%
Clinical Practice Guidelines
16%
Clinically Significant
16%
Co-pathogen
16%
Community-acquired Infections
16%
Confidence Interval
33%
Empiric Antibiotics
100%
Empirical Therapy
16%
In Vitro Susceptibility
16%
Methicillin-resistant Staphylococcus Aureus
100%
Methicillin-resistant Staphylococcus Aureus Infection
16%
Multivariable
16%
Multivariate Association
16%
Odds Ratio
33%
Polymicrobial
16%
Random-effects Meta-analysis
16%
Retrospective Cohort Study
16%
Rifampicin
16%
Staphylococcus Aureus Bacteremia
100%
Stepwise Logistic Regression
16%
Survival Benefit
16%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
20%
Aminoglycoside
20%
Antibiotic Therapy
100%
Bloodstream Infection
20%
Cohort Study
20%
Infection
20%
Infectious Agent
20%
Methicillin Resistant Staphylococcus Aureus Infection
100%
Methicillin-Resistant Staphylococcus Aureus
40%
Rifampicin
20%
Agricultural and Biological Sciences
Aminoglycoside
14%
Bloodstream Infection
100%
Confidence Interval
28%
Meta-Analysis
14%
Methicillin-Resistant Staphylococcus Aureus
100%
Odds Ratio
42%
Rifampicin
14%
Neuroscience
Aminoglycoside
14%
In Vitro
14%
Meta-Analysis
14%
Methicillin-Resistant Staphylococcus Aureus
100%
Rifampicin
14%
Immunology and Microbiology
All Cause Mortality
14%
Infectious Agent
14%
Methicillin-Resistant Staphylococcus Aureus
100%